New flu pill TRX-100 tested in early human trial
NCT ID NCT07371650
First seen Jan 30, 2026 · Last updated May 20, 2026 · Updated 19 times
Summary
This early-stage study tests a new oral drug, TRX-100, in about 105 adults with mild to moderate influenza. Participants take the study drug plus standard flu care. The main goal is to find a safe and effective dose by checking side effects and lab results. Researchers also track how well the drug eases flu symptoms like cough, fever, and body aches.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novatrials
Charlestown, New South Wales, 2290, Australia
Conditions
Explore the condition pages connected to this study.